Trial Profile
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Sponsors Pharmatec
- 09 May 2012 Actual patient number (61) added as reported by ClinicalTrials.gov.
- 09 May 2012 Planned End Date changed from 1 Nov 2010 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 28 Feb 2011 Actual end date (Jan 2011 ) added as reported by ClinicalTrials.gov.